EP Patent

EP1399133B1 — Sustained-release composition comprising lactic acid-glycolic acid copolymer and process for producing the same

Assigned to Takeda Pharmaceutical Co Ltd · Expires 2009-04-29 · 17y expired

What this patent protects

Patent listed against leuprolide-mesylate.

Drugs covered by this patent

leuprolide-mesylate (LEUPROLIDE MESYLATE)

Patent Metadata

Patent number: EP1399133B1
Jurisdiction: EP
Classification: —
Expires: 2009-04-29
Drug substance claim: No
Drug product claim: No
Assignee: Takeda Pharmaceutical Co Ltd
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.